Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Multiple causes of syncope in the elderly: diagnostic outcomes of a Dutch multidisciplinary syncope pathway.

de Ruiter SC, Wold JFH, Germans T, Ruiter JH, Jansen RWMM.

Europace. 2017 May 17. doi: 10.1093/europace/eux099. [Epub ahead of print]

PMID:
28520944
2.

Cognitive Impairment Is Very Common in Elderly Patients With Syncope and Unexplained Falls.

de Ruiter SC, de Jonghe JFM, Germans T, Ruiter JH, Jansen RWMM.

J Am Med Dir Assoc. 2017 May 1;18(5):409-413. doi: 10.1016/j.jamda.2016.11.012. Epub 2017 Jan 17.

PMID:
28108207
3.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
4.

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators.

Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24.

5.

Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial.

Boriani G, Manolis AS, Tukkie R, Mont L, Pürerfellner H, Santini M, Inama G, Serra P, Gulizia M, Samoilenko IV, Wolff C, Holbrook R, Gavazza F, Padeletti L; MINERVA Investigators.

Heart Rhythm. 2015 Jun;12(6):1192-200. doi: 10.1016/j.hrthm.2015.02.017. Epub 2015 Feb 19.

PMID:
25701774
6.

Interaction between digoxin and dronedarone in the PALLAS trial.

Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ; PALLAS investigators.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1019-25. doi: 10.1161/CIRCEP.114.002046. Epub 2014 Nov 6.

7.

Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy.

Verhagen MP, van Boven N, Ruiter JH, Kimman GJ, Tahapary GJ, Umans VA.

Neth Heart J. 2014 Oct;22(10):431-7. doi: 10.1007/s12471-014-0595-z.

8.

Success of electrocardioversion on the elderly.

Stroink JJ, van Boven N, Ruiter JH, Umans VA.

Neth Heart J. 2014 Mar;22(3):100-4. doi: 10.1007/s12471-014-0519-y.

9.

Incidence and predictors of pacemaker reprogramming: potential consequences for remote follow-up.

Udo EO, van Hemel NM, Zuithoff NP, Barrett MJ, Ruiter JH, Doevendans PA, Moons KG.

Europace. 2013 Jul;15(7):978-83. doi: 10.1093/europace/eut002. Epub 2013 Feb 17.

PMID:
23419656
10.

Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial.

Brignole M, Menozzi C, Moya A, Andresen D, Blanc JJ, Krahn AD, Wieling W, Beiras X, Deharo JC, Russo V, Tomaino M, Sutton R; International Study on Syncope of Uncertain Etiology 3 (ISSUE-3) Investigators.

Circulation. 2012 May 29;125(21):2566-71. doi: 10.1161/CIRCULATIONAHA.111.082313. Epub 2012 May 7.

11.

Dronedarone in high-risk permanent atrial fibrillation.

Connolly SJ, Camm AJ, Halperin JL, Joyner C, Alings M, Amerena J, Atar D, Avezum Á, Blomström P, Borggrefe M, Budaj A, Chen SA, Ching CK, Commerford P, Dans A, Davy JM, Delacrétaz E, Di Pasquale G, Diaz R, Dorian P, Flaker G, Golitsyn S, Gonzalez-Hermosillo A, Granger CB, Heidbüchel H, Kautzner J, Kim JS, Lanas F, Lewis BS, Merino JL, Morillo C, Murin J, Narasimhan C, Paolasso E, Parkhomenko A, Peters NS, Sim KH, Stiles MK, Tanomsup S, Toivonen L, Tomcsányi J, Torp-Pedersen C, Tse HF, Vardas P, Vinereanu D, Xavier D, Zhu J, Zhu JR, Baret-Cormel L, Weinling E, Staiger C, Yusuf S, Chrolavicius S, Afzal R, Hohnloser SH; PALLAS Investigators.

N Engl J Med. 2011 Dec 15;365(24):2268-76. doi: 10.1056/NEJMoa1109867. Epub 2011 Nov 14. Erratum in: N Engl J Med. 2012 Feb 16;366(7):672.

12.

Clinical use of automatic pacemaker algorithms: results of the AUTOMATICITY registry.

Alings M, Vireca E, Bastian D, Wardeh AJ, Nimeth C, Tukkie R, Trinks S, Kainz W, Delaney C, Kaltofen G; AUTOMATICITY Study Investigators.

Europace. 2011 Jul;13(7):976-83. doi: 10.1093/europace/eur052. Epub 2011 Mar 21.

PMID:
21422022
13.
14.

The feasibility of fully automated pacemaker advise in treating atrial tachyarrhythmias.

Ruiter JH, Mulder E, Schuchert A, Burri H, Stühlinger MC, Hartikainen J, Sermasi S, Vlasínová J, Mairesse GH, Bub E, Lewalter T; T-STAR Study Group.

Pacing Clin Electrophysiol. 2010 May;33(5):605-14. doi: 10.1111/j.1540-8159.2010.02689.x. Epub 2010 Feb 1.

PMID:
20132506
15.

Prospective evaluation of non-pharmacological treatment in vasovagal syncope.

Romme JJ, Reitsma JB, Go-Schön IK, Harms MP, Ruiter JH, Luitse JS, Lenders JW, Wieling W, van Dijk N.

Europace. 2010 Apr;12(4):567-73. doi: 10.1093/europace/eup414. Epub 2010 Jan 3.

PMID:
20047924
16.

Reproducibility of electrocardiographic findings in patients with suspected reflex neurally-mediated syncope.

Moya A, Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Wieling W, Andresen D, Benditt DG, Garcia-Sacristán JF, Beiras X, Grovale N, Vardas P; International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group.

Am J Cardiol. 2008 Dec 1;102(11):1518-23. doi: 10.1016/j.amjcard.2008.07.043. Epub 2008 Sep 11.

PMID:
19026307
17.

Permanent cardiac pacing for neurocardiogenic syncope.

Ruiter JH, Barrett M.

Neth Heart J. 2008 Oct;16(Suppl 1):S15-9.

18.

Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.

Hemels ME, Ruiter JH, Molhoek GP, Veeger NJ, Wiesfeld AC, Ranchor AV, van Trigt M, Pilmeyer A, Van Gelder IC; Features in AT500TM Study; Chances for Patients with Episodes of Atrial Tachyarrhythmia without Bradycardia Indication for Pacing (FACET) Investigators.

Europace. 2008 Mar;10(3):306-13. doi: 10.1093/europace/eum301. Epub 2008 Feb 1.

PMID:
18245199
19.

Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study.

Camm AJ, Sulke N, Edvardsson N, Ritter P, Albers BA, Ruiter JH, Lewalter T, Capucci PA, Hoffmann E; AFTherapy Investigators.

Europace. 2007 Dec;9(12):1110-8.

PMID:
18042619
20.

Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm.

Pürerfellner H, Ruiter JH, Widdershoven JW, Van Gelder IC, Urban L, Kirchhof CJ, Havlicek A, Kornet L; PMOP Investigators.

Heart Rhythm. 2006 Oct;3(10):1164-71. Epub 2006 Jun 15.

PMID:
17018345

Supplemental Content

Loading ...
Support Center